TY - JOUR A1 - Li, Shan A1 - Li, Xin A1 - Link, Roman A1 - Li, Ren A1 - Deng, Liping A1 - Schuldt, Bernhard A1 - Jiang, Xiaomei A1 - Zhao, Rongjun A1 - Zheng, Jingming A1 - Li, Shuang A1 - Yin, Yafang T1 - Influence of cambial age and axial height on the spatial patterns of xylem traits in Catalpa bungei, a ring-porous tree species native to China JF - Forests N2 - Studying how cambial age and axial height affects wood anatomical traits may improve our understanding of xylem hydraulics, heartwood formation and axial growth. Radial strips were collected from six different heights (0–11.3 m) along the main trunk of three Manchurian catalpa (Catalpa bungei) trees, yielding 88 samples. In total, thirteen wood anatomical vessel and fiber traits were observed usinglight microscopy (LM) and scanning electron microscopy (SEM), and linear models were used to analyse the combined effect of axial height, cambial age and their interaction. Vessel diameter differed by about one order of magnitude between early- and latewood, and increased significantly with both cambial age and axial height in latewood, while it was positively affected by cambial age and independent of height in earlywood. Vertical position further had a positive effect on earlywood vessel density, and negative effects on fibre wall thickness, wall thickness to diameter ratio and length. Cambial age had positive effects on the pit membrane diameter and vessel element length, while the annual diameter growth decreased with both cambial age and axial position. In contrast, early- and latewood fiber diameter were unaffected by both cambial age and axial height. We further observed an increasing amount of tyloses from sapwood to heartwood, accompanied by an increase of warty layers and amorphous deposits on cell walls, bordered pit membranes and pit apertures. This study highlights the significant effects of cambial age and vertical position on xylem anatomical traits, and confirms earlier work that cautions to take into account xylem spatial position when interpreting wood anatomical structures, and thus, xylem hydraulic functioning. KW - wood anatomy KW - vertical and radial variation KW - earlywood KW - latewood KW - growth ring width KW - tyloses KW - pit membrane diameter KW - vessel lumen diameter KW - fibre length Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-196297 SN - 1999-4907 VL - 10 IS - 8 ER - TY - JOUR A1 - Kuai, Yue A1 - Gong, Xin A1 - Ding, Liya A1 - Li, Fang A1 - Lei, Lizhen A1 - Gong, Yuqi A1 - Liu, Qingmeng A1 - Tan, Huajiao A1 - Zhang, Xinxia A1 - Liu, Dongyu A1 - Ren, Guoping A1 - Pan, Hongyang A1 - Shi, Yaoyao A1 - Berberich-Siebelt, Friederike A1 - Ma, Zhengrong A1 - Zhou, Ren T1 - Wilms’ tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90 JF - Cell Communication and Signaling N2 - Background Wilms’ tumor 1-associating protein (WTAP) is a nuclear protein, which is ubiquitously expressed in many tissues. Furthermore, in various types of malignancies WTAP is overexpressed and plays a role as an oncogene. The function of WTAP in diffuse large B-cell lymphoma (DLBCL), however, remains unclear. Methods Immunohistochemistry was applied to evaluate the levels of WTAP expression in DLBCL tissues and normal lymphoid tissues. Overexpression and knock-down of WTAP in DLBCL cell lines, verified on mRNA and protein level served to analyze cell proliferation and apoptosis in DLBCL cell lines by flow cytometry. Finally, co-immunoprecipitation (Co-IP), IP, and GST-pull down assessed the interaction of WTAP with Heat shock protein 90 (Hsp90) and B-cell lymphoma 6 (BCL6) as well as determined the extend of its ubiquitinylation. Results WTAP protein levels were consistently upregulated in DLBCL tissues. WTAP promoted DLBCL cell proliferation and improved the ability to confront apoptosis, while knockdown of WTAP in DLBCL cell lines allowed a significant higher apoptosis rate after treatment with Etoposide, an anti-tumor drug. The stable expression of WTAP was depended on Hsp90. In line, we demonstrated that WTAP could form a complex with BCL6 via Hsp90 in vivo and in vitro. Conclusion WTAP is highly expressed in DLBCL, promoting growth and anti-apoptosis in DLBCL cell lines. WTAP is a client protein of Hsp90 and can appear in a complex with BCL6 and Hsp90 in DLBCL. Down-regulation of WTAP could improve the chemotherapeutic treatments in DLBCL. KW - WTAP KW - BCL6 KW - Hsp90 KW - complex KW - DLBCL Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230168 VL - 16 ER - TY - JOUR A1 - Han, Chao A1 - Ren, Pengxuan A1 - Mamtimin, Medina A1 - Kruk, Linus A1 - Sarukhanyan, Edita A1 - Li, Chenyu A1 - Anders, Hans-Joachim A1 - Dandekar, Thomas A1 - Krueger, Irena A1 - Elvers, Margitta A1 - Goebel, Silvia A1 - Adler, Kristin A1 - Münch, Götz A1 - Gudermann, Thomas A1 - Braun, Attila A1 - Mammadova-Bach, Elmina T1 - Minimal collagen-binding epitope of glycoprotein VI in human and mouse platelets JF - Biomedicines N2 - Glycoprotein VI (GPVI) is a platelet-specific receptor for collagen and fibrin, regulating important platelet functions such as platelet adhesion and thrombus growth. Although the blockade of GPVI function is widely recognized as a potent anti-thrombotic approach, there are limited studies focused on site-specific targeting of GPVI. Using computational modeling and bioinformatics, we analyzed collagen- and CRP-binding surfaces of GPVI monomers and dimers, and compared the interacting surfaces with other mammalian GPVI isoforms. We could predict a minimal collagen-binding epitope of GPVI dimer and designed an EA-20 antibody that recognizes a linear epitope of this surface. Using platelets and whole blood samples donated from wild-type and humanized GPVI transgenic mice and also humans, our experimental results show that the EA-20 antibody inhibits platelet adhesion and aggregation in response to collagen and CRP, but not to fibrin. The EA-20 antibody also prevents thrombus formation in whole blood, on the collagen-coated surface, in arterial flow conditions. We also show that EA-20 does not influence GPVI clustering or receptor shedding. Therefore, we propose that blockade of this minimal collagen-binding epitope of GPVI with the EA-20 antibody could represent a new anti-thrombotic approach by inhibiting specific interactions between GPVI and the collagen matrix. KW - GPVI KW - collagen KW - blood platelets KW - thrombosis KW - anti-thrombotic therapies Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-304148 SN - 2227-9059 VL - 11 IS - 2 ER -